CG Bio said it participated in the Aesthetic and anti-aging Medicine World Congress (AMWC) 2023, an anti-aging conference held in Monte Carlo, Monaco, from March 30 to April 1, and signed supply contracts worth 16.5 billion won ($12.6 million) with Argentina and France. 

Participants visiting CG Bio’s booth at the Aesthetic and anti-aging Medicine World Congress (AMWC) 2023 held in Monte Carlo, Monaco, from March 30 to April 1.
Participants visiting CG Bio’s booth at the Aesthetic and anti-aging Medicine World Congress (AMWC) 2023 held in Monte Carlo, Monaco, from March 30 to April 1.

The company said that it signed the supply contract for its calcium filler Facetem to a supplier in Argentina for 12 billion won and France for 4.5 billion won over three years.

However, the company did not disclose which supplier it had signed the agreement with, citing contractual reasons. 

Also, the company stressed that it held positive discussions regarding the supply of Facetem to distributors in Ecuador and Kazakhstan.

During the conference, CG BIo unveiled its total aesthetic solution products developed based on regenerative medicine technology, including hyaluronic acid (HA) filler Aileene, calcium (CaHA) filler Facetem, SVF fully automatic extraction device Cellunit, breast massager Beluna, microneedle patch Dermaregen, and lifting room Exoft.

Notably, the company stressed that Exoft, which was presented for the first time on the European market, attracted much attention from participants. 

Exoft is composed of two lineups, a 360-degree press-cut PDO (Polydionanone) cog thread with strong facial fixation with patented cog technology, and a PLCL (Polycaprolactone) cog thread with natural and long retention period, which has differentiated competitiveness from existing lifting threads.

"We are pleased to introduce our excellent Korean aesthetic products developed with our proprietary technology at AMWC and receive positive responses from participants," CG Bio CEO Yu Hyun-seung said.

The company is actively targeting overseas markets, including the recent export contract for Giselleigne, a HA filler, to China, and plan further to strengthen its global business activities in the future, Yu added. 

Meanwhile, AMWC is the world's largest congress and exhibition for plastic surgery and aesthetic clinics and attracts more than 10,000 visitors worldwide each year. 

With major players from more than 120 countries participating and showcasing the latest products and technologies in anti-aging, CG Bio held an independent booth at the congress and unveiled its key aesthetic products.

Copyright © KBR Unauthorized reproduction, redistribution prohibited